Evidence map›Paper›PMID 30905674›Full record

ArticleStructure (London, England : 1993)2019

Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα.

Baohua Cao, Tsan-Wen Lu, Juliana A Martinez Fiesco, Michael Tomasini, Lixin Fan, Sanford M Simon, Susan S Taylor, Ping Zhang

Abstract read
In one paragraph

Article in Structure (London, England : 1993), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. N3A motifs in RIβ mediate allosteric crosstalk between cAMP and ATP in PKA activation.Protein science : a publication of the Protein Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. A framework for fibrolamellar carcinoma research and clinical trials.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  13. Review
  14. Review
  15. GPharmacological reviews · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Baohua CaoStructural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Tsan-Wen LuDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Juliana A Martinez FiescoStructural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Michael TomasiniLaboratory of Cellular Biophysics, The Rockefeller University, New York, NY, USA.
Lixin FanSmall-Angle X-ray Scattering Core Facility, Center for Cancer Research of the National Cancer Institute, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.
Sanford M SimonLaboratory of Cellular Biophysics, The Rockefeller University, New York, NY, USA.
Susan S TaylorDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA, USA; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.
Ping ZhangStructural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. Electronic address: ping.zhang@nih.gov.

Funding

Project 4: ImmunovirotherapyP50CA210964 · NCI · MAYO CLINIC ROCHESTER · PI Zongming Eric Chen · 2018 to 2026
$20.5M
Structures and Mechanisms of Kinase Signaling ComplexesZIABC011744 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHANG, PING · 2017 to 2025
$12.6M
Protein Kinase Regulatory Subunit I Directed MutagenesisR01GM034921 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1985 to 2018
$7.2M
Lessons Learned from PKA: Assembly of Dynamic Macromolecular SwitchesR35GM130389 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN S. TAYLOR · 2019 to 2026
$5.7M
Cellular Pathogenesis of Fibrolamellar Hepatocellular CarcinomaR56CA207929 · NCI · ROCKEFELLER UNIVERSITY · PI SIMON, SANFORD M · 2016 to 2017
$593k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011744NCI NIH HHS HHSN261200800001ENCI NIH HHS P50 CA210964NCI NIH HHS R56 CA207929NIGMS NIH HHS R01 GM034921NIGMS NIH HHS R35 GM130389
6 · The paper itself

Abstract

Fibrolamellar hepatocellular carcinoma (FLHCC) is driven by J-PKAcα, a kinase fusion chimera of the J domain of DnaJB1 with PKAcα, the catalytic subunit of protein kinase A (PKA). Here we report the crystal structures of the chimeric fusion RIα

Indexed as

Adenosine TriphosphateAllosteric SiteCarcinoma, HepatocellularCyclic AMP-Dependent Protein Kinase RIalpha SubunitHoloenzymesHumansHydrophobic and Hydrophilic InteractionsLiverLiver NeoplasmsMolecular Dynamics SimulationMotionPeptidesProtein BindingProtein DomainsProtein EngineeringProtein Kinase C-alphaAdenosine TriphosphateCyclic AMP-Dependent Protein Kinase RIalpha SubunitHoloenzymesPeptidesPRKCA protein, humanProtein Kinase C-alphaRecombinant Fusion Proteinsfibrolamellar hepatocellular carcinomakinase fusionPKA holoenzymeprotein kinase PKAstructure

Identifiers

PMID30905674
PMCPMC6506387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.